☆ 4.6 Letter

Cardiorenal benefits of glucagon-like peptide-1 analogues vs. exendin-4 analogues in patients with type 2 diabetes: a meta-analysis based on cardiovascular outcome trials

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Get Full Text
Add to Collection

Journal

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
Volume 29, Issue 7, Pages E243-E245

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/eurjpc/zwab221

Keywords

-

Categories

Cardiac & Cardiovascular Systems

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.